The global non-surgical rhinoplasty market accounted for USD 0.755 billion in 2023 and is expected to reach at USD 1.79 billion by 2034 with a CAGR of 8.16% during the forecast period 2024-2034. The market will grow as a result of factors such as rising awareness and acceptance of aesthetic procedures, growing demand for non-invasive procedures, technological advancements in injectable fillers, quick procedures with immediate results, and growing use by plastic surgeons and dermatologists.
The market for non-surgical rhinoplasty has grown dramatically as a result of the introduction of sophisticated injectable fillers with higher safety profiles, longer-lasting effects, and greater tissue compatibility. Both patients and practitioners now accept non-surgical techniques more widely as a result of these improvements. For instance, in Q4 2023, Merz Pharma announced that they were expanding its Radiesse line to include fillers for non-surgical rhinoplasty.
By filler type, the hyaluronic acid (HA) fillers segment accounted for the highest revenue-grossing segment in the global non-surgical rhinoplasty market in 2023 owing to the high demand for HA fillers due to their safety, effectiveness, and ability to provide long-lasting results with minimal downtime, driving widespread adoption among patients and healthcare professionals alike. For instance, in October 2023, Galderma introduced Restylane Kyalami Lidocaine to the European market. This filler may be used in non-surgical rhinoplasty operations. Additionally, the CaHa fillers segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing advancements in calcium hydroxylapatite (CaHa) filler technology, its versatility in addressing a wide range of nasal concerns, and growing preference for its longer-lasting effects among patients seeking non-surgical rhinoplasty options.
By application, the minor nasal asymmetry segment accounted for the highest revenue-grossing segment in the global non-surgical rhinoplasty market in 2023 owing to the increased awareness among patients about non-surgical options for correcting minor nasal imperfections and the desire for subtle yet noticeable improvements in nasal aesthetics without undergoing invasive surgery. For instance, the SKINovative clinic has launched the SKINovative ELITE VIP Membership, which is designed to provide its members with a personalized and consistent regimen at a reduced rate. Additionally, the indentations of the dorsal hump segment is predicted to grow at the fastest CAGR during the forecast period owing to the growing demand for non-surgical solutions to address dorsal hump deformities, driven by the desire for nasal contouring and refinement without the need for invasive surgery or prolonged recovery periods.
By end-user, the MedSpa segment accounted for the highest revenue-grossing segment in the global non-surgical rhinoplasty market in 2023 owing to the increasing popularity of non-surgical rhinoplasty procedures offered in medical spas due to their convenience, accessibility, and ability to provide a luxurious experience for patients seeking cosmetic enhancements in a relaxing environment. For instance, in 2023, SKINovative of Gilbert launched the SKINovative ELITE VIP Membership, which offers members a subsidized, personalized, and consistent program. Additionally, the HCP-owned clinics segment is predicted to grow at the fastest CAGR during the forecast period owing to the growing trend of healthcare professionals (HCPs) expanding their service offerings to include non-surgical rhinoplasty procedures, driven by increased patient demand, trust in medical expertise, and the ability to provide comprehensive aesthetic solutions under the supervision of qualified practitioners.
North American region is anticipated to have the highest revenue share during the forecast period owing to the high disposable income levels, increasing aesthetic consciousness, advanced healthcare infrastructure, and widespread adoption of cosmetic procedures, including non-surgical rhinoplasty, among the population in North America. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rapidly expanding middle-class population, rising disposable incomes, growing awareness and acceptance of cosmetic procedures, including non-surgical rhinoplasty, and increasing availability of advanced aesthetic technologies and treatments in the Asia Pacific region. For instance, the International Society of Aesthetic Plastic Surgery stated in its 2021 press release that demand for non-surgical aesthetic treatments such as fillers increased significantly following the pandemic due to increased social media influence, disposable income, and aesthetic consciousness.
This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.
The market for non-surgical rhinoplasty has grown dramatically as a result of the introduction of sophisticated injectable fillers with higher safety profiles, longer-lasting effects, and greater tissue compatibility. Both patients and practitioners now accept non-surgical techniques more widely as a result of these improvements. For instance, in Q4 2023, Merz Pharma announced that they were expanding its Radiesse line to include fillers for non-surgical rhinoplasty.
By filler type, the hyaluronic acid (HA) fillers segment accounted for the highest revenue-grossing segment in the global non-surgical rhinoplasty market in 2023 owing to the high demand for HA fillers due to their safety, effectiveness, and ability to provide long-lasting results with minimal downtime, driving widespread adoption among patients and healthcare professionals alike. For instance, in October 2023, Galderma introduced Restylane Kyalami Lidocaine to the European market. This filler may be used in non-surgical rhinoplasty operations. Additionally, the CaHa fillers segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing advancements in calcium hydroxylapatite (CaHa) filler technology, its versatility in addressing a wide range of nasal concerns, and growing preference for its longer-lasting effects among patients seeking non-surgical rhinoplasty options.
By application, the minor nasal asymmetry segment accounted for the highest revenue-grossing segment in the global non-surgical rhinoplasty market in 2023 owing to the increased awareness among patients about non-surgical options for correcting minor nasal imperfections and the desire for subtle yet noticeable improvements in nasal aesthetics without undergoing invasive surgery. For instance, the SKINovative clinic has launched the SKINovative ELITE VIP Membership, which is designed to provide its members with a personalized and consistent regimen at a reduced rate. Additionally, the indentations of the dorsal hump segment is predicted to grow at the fastest CAGR during the forecast period owing to the growing demand for non-surgical solutions to address dorsal hump deformities, driven by the desire for nasal contouring and refinement without the need for invasive surgery or prolonged recovery periods.
By end-user, the MedSpa segment accounted for the highest revenue-grossing segment in the global non-surgical rhinoplasty market in 2023 owing to the increasing popularity of non-surgical rhinoplasty procedures offered in medical spas due to their convenience, accessibility, and ability to provide a luxurious experience for patients seeking cosmetic enhancements in a relaxing environment. For instance, in 2023, SKINovative of Gilbert launched the SKINovative ELITE VIP Membership, which offers members a subsidized, personalized, and consistent program. Additionally, the HCP-owned clinics segment is predicted to grow at the fastest CAGR during the forecast period owing to the growing trend of healthcare professionals (HCPs) expanding their service offerings to include non-surgical rhinoplasty procedures, driven by increased patient demand, trust in medical expertise, and the ability to provide comprehensive aesthetic solutions under the supervision of qualified practitioners.
North American region is anticipated to have the highest revenue share during the forecast period owing to the high disposable income levels, increasing aesthetic consciousness, advanced healthcare infrastructure, and widespread adoption of cosmetic procedures, including non-surgical rhinoplasty, among the population in North America. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rapidly expanding middle-class population, rising disposable incomes, growing awareness and acceptance of cosmetic procedures, including non-surgical rhinoplasty, and increasing availability of advanced aesthetic technologies and treatments in the Asia Pacific region. For instance, the International Society of Aesthetic Plastic Surgery stated in its 2021 press release that demand for non-surgical aesthetic treatments such as fillers increased significantly following the pandemic due to increased social media influence, disposable income, and aesthetic consciousness.
This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Filler Type, Application and End-User
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of the Top 10+ Major Market Players
Segmentation: Non-surgical Rhinoplasty Market Report 2023 - 2034
Non-surgical Rhinoplasty Market Analysis & Forecast by Filler Type 2023 - 2034 (Revenue USD Bn)
- Hyaluronic Acid Fillers
- CaHa Fillers
Non-surgical Rhinoplasty Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Indentations of dorsal hump
- Convex Nose
- Minor Nasal Asymmetry
- Others
Non-surgical Rhinoplasty Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Bn)
- MedSpa
- Hospital/Surgery Center
- HCP-owned clinic
Non-surgical Rhinoplasty Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Non-surgical Rhinoplasty Market: Filler Type Estimates & Trend Analysis
8. Non-surgical Rhinoplasty Market: Application Estimates & Trend Analysis
9. Non-surgical Rhinoplasty Market: End-User Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Non-surgical Rhinoplasty Market
12. Europe Global Non-surgical Rhinoplasty Market
13. Asia Pacific Global Non-surgical Rhinoplasty Market
14. Latin America Global Non-surgical Rhinoplasty Market
15. MEA Global Non-surgical Rhinoplasty Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- SKINovative of Gilbert - Medical Spa
- The London Cosmetic Clinic
- Laser Clinic United Kingdom
- Therapie Clinic
- Toronto Cosmetic Clinic (TCC)
- Canada MedLaser Inc.
- Skin Vitality Medical Clinic
- True MediSpa
- Nova Aesthetic Clinic
- VIVA Skin Clinic
- Piedmont Plastic Surgery & Dermatology.
